Perseus Biomics SRL
14.3 FTEPerseus Biomics reported total assets of €5.25m at the end of the 2025 financial year (annual accounts filed with the NBB on 29 Jul 2026), with 14.3 full-time equivalents.
The score of Perseus Biomics shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +6021 % Total assets +22 % Headcount (avg FTE) +17 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Perseus Biomics's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 29 Jul 2026
- Year ended 31 Dec 2024filed on 07 Aug 2025
- Year ended 31 Dec 2023filed on 18 Jul 2024
- Year ended 31 Dec 2022filed on 23 Aug 2023
- Year ended 31 Dec 2021filed on 15 Jul 2022
Perseus Biomics's financial analysis
- Solvency39.2%sector median: 56.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Perseus Biomics
Perseus Biomics's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0650.946.412
- VAT number
- BE0650946412
- Peppol
- Registered · 0208:0650946412 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 31 Mar 2016
- Registered office
- 3001 Leuven
- Size
- Small · 14.3 FTE
- Latest accounts
- 2025 · filed on 29 Jul 2026
- Activity
- Manufacture of basic pharmaceutical products (NACE 21100)
Perseus Biomics (SRL) has been based in Leuven since 2016, active in: manufacture of basic pharmaceutical products. For 2025, it reports a net loss of €2.46m and equity of €2.06m; its revenue is not published. With 14.3 full-time equivalents, it is a small enterprise by headcount. Its solvency stands at 39.2%, below the median of its sector (56.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Perseus Biomics
Companies in the same business, of comparable size and area, outside its group.
- Simabs Manufacture of pharmaceutical preparations Diepenbeek · balance sheet €2.67m
- Boehringer Ingelheim Veterinary Medicine Belgium NV Research and experimental development on natural sciences and engineering Evergem · balance sheet €6.51m
- Rejuvenate Biomed Research and experimental development on natural sciences and engineering Diepenbeek · balance sheet €3.45m
- Grand Medical (Europe) Research and experimental development on natural sciences and engineering Niel · balance sheet 135,260 €
- White Raven Manufacture of pharmaceutical preparations Liège · balance sheet €9.55m
- GRNR Invest Manufacture of basic pharmaceutical products Zemst · balance sheet €2.26m
- Curium PET Liège Manufacture of basic pharmaceutical products Liège · balance sheet €1.86m
- Sartorius Xpress Biologics Manufacture of basic pharmaceutical products Herstal · balance sheet €10.9m
Frequently asked questions about Perseus Biomics
What is the revenue of Perseus Biomics?
Perseus Biomics files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Perseus Biomics?
In Belgium, the VAT number is the company number prefixed with BE: BE0650946412 for Perseus Biomics, if the company is VAT-registered. Its company number (CBE) is 0650.946.412.
Where is the registered office of Perseus Biomics?
According to the CBE register, the registered office of Perseus Biomics is in 3001 Leuven.
What is the equity of Perseus Biomics?
At the close of the 2025 financial year, the equity of Perseus Biomics amounts to 2,057,143 €, a solvency of 39.2% of total assets.
How many people work at Perseus Biomics?
14.3 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Perseus Biomics?
The register lists 7 active mandates at Perseus Biomics. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Perseus Biomics
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →